Janssen-Cilag Farmaceutica

Part of Johnson & Johnson

CompanyBrazilFounded 1982

Janssen-Cilag Farmaceutica develops one asset, in phase 3, no development reported (Norelgestromine (NLGM)/ethinyl estradiol (EE) in contraception). Mostly small molecule; based in Brazil, founded in 1982.

1
Asset
Furthest stage
Phase 3, no development reported
3
Trials
0
Signals

Pipeline

1

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials4
  • Similar companies6

Intelligence